S 4327

119th Congress • 2025-2027 (Current)

A bill to require regulatory review of pharmaceutical products from Chinese entities, and for other purposes.

---

Bill Number

S 4327

Introduced

Apr 16, 2026

Latest Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Sponsor

Sen. Tom Cotton (R-AR)

Cosponsors

Topics

Full Text

View Full Bill Text

Votes

Summary

No summary available.

Actions

• Apr 16, 2026
  Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
• Apr 16, 2026
  Introduced in Senate

Amendments

Related Bills

• No related bills.